You are using IPv4 from 216.73.217.61
Main Headlines
New IPv6 Book "IPv6 for All"
Enable project releases Mobility publication
The Choice: IPv4 Exhaustion or Transition to IPv6
Consulintel: logos
 
SEARCH
Are you a...?
> ISP
Keep informed, visit our
Tell us your thoughts
on IPv6 > POLL
Looking for an
IPv6 Task Force? >
Questions? > FAQS
Jump to PROJECTS
Next EVENTS
000 members
036 guests
LOGIN 
Password 
Not member yet?
Get "extras". Register
Search Bar Plug-in
Firefox      IE7
Other News
(Oct 02, 2003)
(Sep 25, 2003)
(Sep 25, 2003)
(Sep 25, 2003)
(Sep 22, 2003)
(Sep 22, 2003)
(Sep 22, 2003)
(Sep 20, 2003)
(Sep 20, 2003)
(Sep 20, 2003)
(Sep 20, 2003)
(Sep 20, 2003)
IP Infusion Announces IP Routing Suite Support Plans for Intel with IPv6
Posted by: Jordi on Saturday, September 20, 2003 - 11:15 AM
(221140 Reads) comments? Send this story to a friend Printer friendly page
IP Infusion, a leading provider of intelligent network software for enhanced IP services, announced today its intention to support the Intel® IXP2400, IXP2800 and IXP2850 network processors and newly announced development environment. With its ZebOS® Advanced Routing Suite, IP Infusion plans to continue to provide enhanced IP routing protocol support for Intel network processors.

IP Infusion's latest ZebOS version features interface software that maps IP Infusion's NPapi control plane to the Intel® Control Plane Platform Development Kit (CP-PDK). The NPapi supports route table creation, call back functions, and adding and deleting table entries for IPv4 and IPv6. Using the NPapi, hardware manufacturers can easily develop a communication interface between their network processors and ZebOS protocol modules. Additionally, ZebOS delivers a broad set of Layer 2 and 3 products that are portable to the Intel network processors. Layer 2 products include Spanning Tree Protocol, Rapid Spanning Tree Protocol, 802.1x Port Authentication, and VLANs; Layer 3 products include IPv4, IPv6, Multicast, MPLS, Traffic Engineering, DiffServ, and VPN protocols.

Click here for the complete press info.